PCM
TECX

Penserra Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Penserra Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83
Closed -$5K – 1579
2021
Q3 		$5K Buy
83
+4
+5% +$328 ﹤0.01% 1411
2021
Q2 		$8K Buy
79
+1
+1% +$119 ﹤0.01% 1289
2021
Q1 		$11K Sell
78
-1
-1% -$163 ﹤0.01% 1032
2020
Q4 		$13K Buy
79
+53
+204% +$9.42K ﹤0.01% 903
2020
Q3 		$4K Buy
+26
New +$5.24K ﹤0.01% 874

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Penserra Capital Management's TECX Position: Q4 2021 in Review

Penserra Capital Management sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 83 shares — an estimated $5K sold.

Penserra Capital Management first reported a position in TECX in Q3 2020 and held it in 5 quarters. The position peaked at $13K in Q4 2020. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • Penserra Capital Management reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 83 Tectonic Therapeutic shares in Q4 2021, an estimated $5K.
  • Penserra Capital Management first reported a position in Tectonic Therapeutic in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Tectonic Therapeutic position peaked at $13K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.